Taipei, Sunday, May 26, 2013 05:42 (GMT+8)
mostly cloudy
Taipei
25°C
Biostar launches AMD 760G-based motherboard - related company info
Press release, January 20; Joseph Tsai, DIGITIMES [Tuesday 20 January 2009]
  • Biostar Microtech International
  • Brief

    Full name: Biostar Microtech International

    Chinese name: 映泰股份有限公司

    Short name: Biostar

    Stock code: 2399

    Tax ID: 23826200

    Market: TSE

    Established: 29 Aug 1990

    Paid in capital: NT$1.78 billion

    Listed on TSE: 16 Dec 1999

    Website: www.biostar.com.tw

  • On display

    Biostar G41 chipset motherboard

    Biostar G41 chipset motherboard

    Photo: Company, Jul 13.

    Biostar TA790GX A3+ motherboard

    Biostar TA790GX A3+ motherboard

    Photo: Company, Feb 16.

    Biostar TA760G M2+ motherboard

    Biostar TA760G M2+ motherboard

    Photo: Company, Jan 22.

  • Financial performance
    Biostar [2399] historical stock price (NT$)
    DateVolume (k)TransactionsValueOpenHighLowCloseChangeAskBid
    24-May 457 181 5,367,085 11.95 11.95 11.65 11.65-0.30-2.51% 11.75 11.65
    23-May 1,501 432 17,817,877 12.00 12.15 11.70 11.95-0.05-0.42% 11.95 11.85
    22-May 5,076 1,161 60,357,335 11.75 12.10 11.75 12.00+0.25+2.13% 12.00 11.95
    21-May 2,670 632 31,160,317 11.65 11.85 11.55 11.75+0.05+0.43% 11.75 11.70
    20-May 4,433 1,059 51,231,100 11.30 11.80 11.20 11.70+0.40+3.54% 11.75 11.70
    17-May 532 189 6,020,814 11.20 11.40 11.20 11.30-0.05-0.44% 11.30 11.25
    • Source: TSE, compiled by Digitimes

    Biostar: Consolidated revenues, Apr 2012 - Apr 2013 (NT$m)

    Month

    Sales

    M/M

    Y/Y

    YTD

    Y/Y

    Apr-13

    361

    (1.2%)

    (12.8%)

    1,521

    (19.1%)

    Mar-13

    366

    4.8%

    (29.4%)

    1,159

    (20.9%)

    Feb-13

    349

    (21.7%)

    (32.6%)

    794

    (16.3%)

    Jan-13

    445

     

    3.3%

    445

    3.3%

    Apr-12

    414

    (20%)

     

    1,880

     

    Mar-12

    518

    0.2%

     

    1,466

     

    Feb-12

    517

    19.9%

     

    948

     

    Jan-12

    431

     

     

    431

     

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, May 2013

    Biostar: Non-consolidated revenues, Dec 2011 - Dec 2012 (NT$m)

    Month

    Sales

    M/M

    Y/Y

    YTD

    Y/Y

    Dec-12

    405

    (0%)

    1.4%

    4,977

    (27.9%)

    Nov-12

    405

    8.2%

    (5.1%)

    4,571

    (29.7%)

    Oct-12

    374

    (5.8%)

    (33.7%)

    4,166

    (31.5%)

    Sep-12

    398

    2.3%

    (29.6%)

    3,792

    (31.2%)

    Aug-12

    389

    (3.8%)

    (34.4%)

    3,395

    (31.4%)

    Jul-12

    404

    3.5%

    (35%)

    3,006

    (31%)

    Jun-12

    390

    (13.5%)

    (39.3%)

    2,602

    (30.3%)

    May-12

    451

    6.7%

    (20.4%)

    2,212

    (28.5%)

    Apr-12

    423

    (19.9%)

    (37.8%)

    1,760

    (30.3%)

    Mar-12

    529

    22.6%

    (23%)

    1,337

    (27.5%)

    Feb-12

    431

    14.2%

    (12.8%)

    809

    (30.2%)

    Jan-12

    378

    (5.5%)

    (43.2%)

    378

    (43.2%)

    Dec-11

    400

    (6.4%)

    (23.6%)

    6,905

    3.3%

    *Figures are not consolidated
    Source: TSE, compiled by Digitimes, May 2013

    Biostar: Consolidated revenues, 1Q12 - 1Q13 (NT$m)

    Quarter

    Sales

    Q/Q

    Y/Y

    YTD

    Y/Y

    1Q-13

    1,159

    (4.7%)

    (20.9%)

    1,159

    (20.9%)

    4Q-12

    1,217

    (9.2%)

    (24%)

    5,358

    (22.9%)

    3Q-12

    1,340

    0.4%

    (25.3%)

    4,141

    (22.6%)

    2Q-12

    1,335

    (8.9%)

    (26%)

    2,801

    (21.2%)

    1Q-12

    1,466

    (8.5%)

    (16.1%)

    1,466

    (16.1%)

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, May 2013

    Biostar: Non-consolidated revenues, 4Q11 - 4Q12 (NT$m)

    Quarter

    Sales

    Q/Q

    Y/Y

    YTD

    Y/Y

    4Q-12

    1,185

    (0.5%)

    (14.9%)

    4,977

    (27.9%)

    3Q-12

    1,190

    (5.9%)

    (33.1%)

    3,792

    (31.2%)

    2Q-12

    1,265

    (5.4%)

    (33.1%)

    2,602

    (30.3%)

    1Q-12

    1,337

    (3.9%)

    (27.5%)

    1,337

    (27.5%)

    4Q-11

    1,391

    (21.8%)

    (11.5%)

    6,905

    3.3%

    *Figures are not consolidated
    Source: TSE, compiled by Digitimes, May 2013

    Biostar: Consolidated balance sheet, 4Q11 - 4Q12 (NT$k)

    Item

    4Q-2012

    3Q-2012

    2Q-2012

    1Q-2012

    4Q-2011

    Current assets

    3,162,474

    3,077,222

    3,399,323

    3,413,884

    3,534,734

    Other assets

    247,665

    249,469

    268,670

    269,233

    268,668

    Assets

    3,756,757

    3,692,919

    4,041,062

    4,007,424

    4,132,055

    Current liabilities

    1,174,591

    1,107,689

    1,466,387

    1,212,780

    1,378,022

    Other liabilities

    12,012

    14,159

    12,372

    20,721

    18,088

    Liabilities

    1,186,603

    1,121,848

    1,478,759

    1,233,501

    1,396,110

    Stockholders' equity

    2,570,154

    2,571,071

    2,562,303

    2,773,923

    2,735,945

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, May 2013

    Biostar: Non-consolidated balance sheet, 4Q11 - 4Q12 (NT$k)

    Item

    4Q-2012

    3Q-2012

    2Q-2012

    1Q-2012

    4Q-2011

    Current assets

    3,039,529

    2,955,757

    3,287,238

    3,255,307

    3,408,638

    Long-term investments

    381,069

    378,004

    379,821

    375,637

    394,347

    Other assets

    239,128

    240,272

    257,902

    259,494

    258,316

    Assets

    3,820,505

    3,752,985

    4,105,930

    4,015,295

    4,187,699

    Current liabilities

    1,235,873

    1,169,417

    1,517,425

    1,210,772

    1,397,889

    Other liabilities

    14,478

    12,497

    26,202

    30,600

    53,865

    Liabilities

    1,250,351

    1,181,914

    1,543,627

    1,241,372

    1,451,754

    Stockholders' equity

    2,570,154

    2,571,071

    2,562,303

    2,773,923

    2,735,945

    *Figures are not consolidated
    Source: TSE, compiled by Digitimes, May 2013

    Biostar: Consolidated income statement, 1Q12 - 1Q13 (NT$k)

    Item

    1Q-2013

    4Q-2012

    3Q-2012

    2Q-2012

    1Q-2012

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    Operating revenue

    1,159,334

     

    1,217,044

     

    1,339,807

     

    1,335,079

     

    1,465,753

     

    Gross profit (loss) from operations

    122,042

     

    131,881

     

    212,666

     

    148,135

     

    177,243

     

    Operating expenses

    94,850

     

    117,320

     

    193,816

     

    106,835

     

    112,936

     

    Operating income (loss)

    27,192

     

    14,561

     

    18,850

     

    41,300

     

    64,307

     

    Non-operating revenues and gains

     

     

    8,537

     

    13,281

     

    12,357

     

    12,096

     

    Income from continuing operations before income tax

    67,557

     

    -1,768

     

    9,918

     

    67,993

     

    48,195

     

    Net income (loss)

    56,557

     

    867

     

    6,052

     

    52,993

     

    38,171

     

    Fully-diluted earnings per share (NT$)

    0.3

     

    0

     

    0

     

    0.3

     

    0.2

     

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, May 2013

    Biostar: Non-consolidated income statement, 4Q11 - 4Q12 (NT$k)

    Item

    4Q-2012

    3Q-2012

    2Q-2012

    1Q-2012

    4Q-2011

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    Operating revenue

    1,184,524

     

    1,190,086

     

    1,264,974

     

    1,337,067

     

    1,391,046

     

    Gross profit (loss) from operations

    118,831

     

    111,087

     

    138,409

     

    144,709

     

    127,482

     

    Operating expenses

    107,227

     

    112,733

     

    104,353

     

    92,836

     

    217,453

     

    Operating income (loss)

    9,287

     

    11,721

     

    38,106

     

    74,472

     

    -77,085

     

    Non-operating revenues and gains

    15,529

     

    10,227

     

    14,783

     

    10,691

     

    16,164

     

    Income from continuing operations before income tax

    3,867

     

    6,052

     

    67,993

     

    48,171

     

    -61,736

     

    Net income (loss)

    867

     

    6,052

     

    52,993

     

    38,171

     

    -63,736

     

    Fully-diluted earnings per share (NT$)

    0

     

    0

     

    0.3

     

    0.2

     

    -0.4

     

    *Figures are not consolidated
    Source: TSE, compiled by Digitimes, May 2013

24-May-2013 markets closed

 LastChange

TAIEX (TSE)8209.78-28.05-0.34% 

TSE electronic310.89-0.43-0.14% 

GTSM (OTC)118.64-0.71-0.59% 

OTC electronic143.77-0.29-0.2% 

MSI GK-601 Mechanical Gaming Keyboard
Smartphone industry and market, 2013 forecast
2013 global tablet forecast
  • Trends and shipment forecast for 2H 2012 tablet market

    Digitimes Research remains conservative about the prospects for the period, with half-year shipments projected to reach 49.18 million units and whole-year shipments being revised downward to 88.69 million units.

  • Trends in the China video market

    In addition to strong potential video content demand in China, the market has developed rapidly due to government intervention and delays in establishing copyright protections.

  • 4Q12 trends in the Greater China touch panel industry

    In the second half of 2012, the market focus is on the iPhone 5, which uses in-cell touch screen technology. Due to the integration of display panels and touch panel functions, the high technological threshold will mean Taiwan touch panel makers are unable to enter the iPhone supply chain.